OncoVent initiates clinical development program for AR20.5 for the treatment of pancreatic cancer Nov. 3, 2016
Bellicum Pharmaceuticals and OPBG to collaborate using Bellicum's molecular safety switch technology Nov. 2, 2016
Combination of MEDI-0680 and durvalumab feasible and active in advanced solid malignancies Oct. 31, 2016
RSS